HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiyuki Ueno Selected Research

Lipids

1/2017Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
1/2015Association of Treatment for Hyperlipidemia with Decreased Total Mortality in Japanese Individuals: the Yamagata (Takahata) Study.
8/2010Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiyuki Ueno Research Topics

Disease

34Fibrosis (Cirrhosis)
02/2024 - 08/2006
29Infections
04/2024 - 06/2005
23Neoplasms (Cancer)
11/2023 - 04/2004
22Hepatocellular Carcinoma (Hepatoma)
08/2022 - 04/2004
22Chronic Hepatitis C
01/2021 - 04/2002
20Cholestasis
06/2014 - 05/2002
19Inflammation (Inflammations)
04/2024 - 10/2004
19Liver Diseases (Liver Disease)
02/2024 - 10/2004
13Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2020 - 02/2003
12Liver Cirrhosis (Hepatic Cirrhosis)
07/2021 - 08/2002
10Hepatitis
01/2021 - 12/2002
9Hepatitis C
10/2023 - 10/2003
7Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2015
7Hyperplasia
10/2014 - 05/2007
6Chronic Hepatitis B
10/2023 - 11/2004
6Body Weight (Weight, Body)
01/2023 - 08/2009
6Non-alcoholic Fatty Liver Disease
04/2022 - 01/2008
5Hepatitis B
08/2021 - 11/2004
5Necrosis
04/2021 - 10/2004
5Cholangiocarcinoma
01/2021 - 12/2004
5Acute Liver Failure (Fulminant Hepatic Failure)
10/2020 - 02/2005
4Insulin Resistance
04/2022 - 06/2013
4Obesity
04/2022 - 01/2014
4End Stage Liver Disease
01/2022 - 10/2006
4Alcoholic Fatty Liver
07/2021 - 08/2010
4Anemia
01/2019 - 04/2014
4Autoimmune Hepatitis
07/2016 - 06/2005
4Massive Hepatic Necrosis
10/2012 - 02/2005
4Virus Diseases (Viral Diseases)
01/2012 - 06/2005
4Hepatitis E
01/2010 - 06/2005
3Chronic Renal Insufficiency
10/2023 - 01/2018
3Esophageal and Gastric Varices (Esophageal Varices)
10/2023 - 07/2016
3Adenoma (Adenomas)
04/2022 - 01/2018
3Hepatic Encephalopathy
03/2022 - 02/2005
3Liver Failure
01/2022 - 11/2016
3Ascites
07/2021 - 07/2016
3Proteinuria
11/2020 - 08/2016
3Cholelithiasis
12/2019 - 12/2012
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2018 - 06/2014
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018 - 01/2014
3Disease Progression
11/2016 - 06/2005
3Albuminuria
08/2016 - 08/2013

Drug/Important Bio-Agent (IBA)

20Antiviral Agents (Antivirals)IBA
12/2023 - 08/2006
18Ribavirin (Virazole)FDA LinkGeneric
10/2023 - 05/2004
17InterferonsIBA
08/2022 - 04/2002
14Proteins (Proteins, Gene)FDA Link
04/2024 - 12/2004
9CytokinesIBA
02/2024 - 02/2003
9Alanine Transaminase (SGPT)IBA
01/2022 - 07/2010
8AlbuminsIBA
11/2023 - 12/2013
7Bile Acids and Salts (Bile Acids)IBA
02/2024 - 05/2002
7Messenger RNA (mRNA)IBA
03/2022 - 04/2002
7AntibodiesIBA
01/2018 - 06/2005
6SofosbuvirIBA
01/2021 - 11/2014
6Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2005
6RNA (Ribonucleic Acid)IBA
12/2020 - 05/2004
6CreatinineIBA
01/2020 - 12/2013
6SecretinFDA Link
06/2014 - 04/2003
5BilirubinIBA
11/2023 - 02/2005
5DNA (Deoxyribonucleic Acid)IBA
10/2021 - 12/2004
5AdiponectinIBA
11/2016 - 01/2014
5MicroRNAs (MicroRNA)IBA
11/2016 - 03/2007
5Bicarbonates (Hydrogen Carbonate)IBA
07/2013 - 11/2004
5Amino AcidsFDA Link
06/2013 - 12/2009
4entecavirFDA Link
10/2023 - 10/2007
4EnzymesIBA
01/2021 - 04/2004
4CholesterolIBA
12/2019 - 12/2012
4Fatty Acid Binding Protein 3IBA
02/2018 - 01/2012
4NucleotidesIBA
01/2018 - 06/2008
4Hepatitis B e AntigensIBA
01/2017 - 08/2002
4Interleukin-6 (Interleukin 6)IBA
01/2015 - 06/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2014 - 04/2006
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2014 - 02/2003
4Interferon-alpha (Interferon Alfa)IBA
05/2010 - 04/2002
4Lamivudine (Epivir)FDA Link
10/2007 - 12/2002
3Immunoglobulins (Immunoglobulin)IBA
05/2024 - 04/2008
3Cytidine Triphosphate (CTP)IBA
10/2023 - 10/2017
3Capsules (Microcapsules)IBA
12/2022 - 01/2015
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 11/2015
3Prothrombin (Factor II)IBA
04/2021 - 01/2008
3velpatasvirIBA
01/2021 - 07/2018
3sofosbuvir drug combination ledipasvirIBA
10/2020 - 06/2015
3Fibrinogen (Factor I)FDA Link
01/2020 - 01/2016
3Uric Acid (Urate)IBA
12/2019 - 08/2013
3Insulin (Novolin)FDA Link
01/2018 - 01/2015
3Glucose (Dextrose)FDA LinkGeneric
01/2018 - 05/2010
3Transcription Factors (Transcription Factor)IBA
01/2017 - 03/2007
3LipidsIBA
01/2017 - 08/2010
3NitrogenIBA
01/2016 - 02/2005
3AntigensIBA
10/2015 - 01/2007
3AutoantibodiesIBA
08/2015 - 06/2005
3Immunoglobulin M (IgM)IBA
08/2015 - 02/2007
3Triglycerides (Triacylglycerol)IBA
01/2015 - 08/2010
3Transaminases (Aminotransferases)IBA
12/2014 - 01/2010
3InterleukinsIBA
09/2014 - 04/2002
3secretin receptorIBA
07/2013 - 07/2010

Therapy/Procedure

54Therapeutics
08/2022 - 04/2002
11Ligation
10/2023 - 10/2004
9Liver Transplantation
01/2022 - 02/2005
5Renal Dialysis (Hemodialysis)
07/2019 - 01/2017
3Aftercare (After-Treatment)
07/2019 - 09/2006